Cardiovascular phenotype of mice lacking all three subtypes of angiotensin II receptors.
Angiotensin II activates two distinct receptors, the angiotensin II receptors type 1 (AT(1)) and type 2 (AT(2)). In rodents, two AT(1) subtypes were identified (AT(1a) and AT(1b)). To determine receptor-specific functions and possible angiotensin II effects independent of its three known receptors we generated mice deficient in either one of the angiotensin II receptors, in two, or in all three (triple knockouts). Triple knockouts were vital and fertile, but survival was impaired. Hypotension and renal histological abnormalities in triple knockouts were comparable to those in mice lacking both AT(1) subtypes. All combinations lacking AT(1a) were distinguished by reduced heart rate. AT(1a) deletion impaired the in vivo pressor response to angiotensin II bolus injection, whereas deficiency for AT(1b) and/or AT(2) had no effect. However, the additional lack of AT(1b) in AT(1a)-deficient mice further impaired the vasoconstrictive capacity of angiotensin II. Although general vasoconstrictor properties were not changed, angiotensin II failed to alter blood pressure in triple knockouts, indicating that there are no other receptors involved in direct angiotensin II pressor effects. Our data identify mice deficient in all three angiotensin II receptors as an ideal tool to better understand the structure and function of the renin-angiotensin system and to search for angiotensin II effects independent of AT(1) and AT(2).
Gembardt
Florian
F
Department of Cardiology, Charité Berlin, Campus Benjamin Franklin, Berlin, Germany.
Heringer-Walther
Silvia
S
van Esch
Joep H M
JH
Sterner-Kock
Anja
A
van Veghel
Richard
R
Le
Thu H
TH
Garrelds
Ingrid M
IM
Coffman
Thomas M
TM
Danser
A H Jan
AH
Schultheiss
Heinz-Peter
HP
Walther
Thomas
T
D000804:Angiotensin II / Q000008:administration & dosage / Q000097:blood; D000818:Animals; D001483:Base Sequence; D001794:Blood Pressure / Q000187:drug effects / Q000235:genetics / Q000502:physiology*; D017931:DNA Primers / Q000235:genetics; D006339:Heart Rate / Q000187:drug effects / Q000235:genetics / Q000502:physiology; D007668:Kidney / Q000473:pathology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D010641:Phenotype; D044140:Receptor, Angiotensin, Type 1 / Q000172:deficiency / Q000235:genetics / Q000502:physiology; D044139:Receptor, Angiotensin, Type 2 / Q000145:classification / Q000172:deficiency* / Q000235:genetics / Q000502:physiology; D012084:Renin-Angiotensin System / Q000235:genetics / Q000502:physiology; D014661:Vasoconstriction / Q000235:genetics / Q000502:physiology
D017931:DNA Primers; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D000804:Angiotensin II